Adropin peptide
Adropin peptide has been studied in 1 paper since 2020: none in people yet, 1 in animals. The research so far is in animals. The newest paper, Jul 29, 2020: “Hepatocyte expression of the micropeptide adropin regulates the liver fasting response and is enhanced by caloric restriction”.
1 paper studies it1 findingUpdated
See all 1 papers on adropin peptide
At a glance
The findings reach mice, none yet in people. 1 lab in 1 country.
- 1 lab in 1 country
- Funders: National Heart, Lung, and Blood Institute and 1 more
- Animals1
What did studies of adropin peptide find?
1Studies of adropin peptide measured 1 outcome; the most studied are fasting-induced cAMP-dependent PKA signaling (1 study).
fasting-induced cAMP-dependent PKA signaling
downin mice1
1 study
fasting-induced cAMP-dependent PKA signaling
downin mice1
Adropin peptide decreases fasting-induced cAMP-dependent PKA signaling in mice (fasting mice).
“Fasting-associated changes in PKA signaling are attenuated in transgenic mice constitutively expressing adropin and in fasting mice treated acutely with adropin peptide.”
Animalsfasting miceliver
The Journal of biological chemistry